Integrating patient-reported outcomes into cancer clinical trials

Speaker: Massimo di Maio

M. Di Maio discusses about incorporation of patient-reported outcomes in defining and reporting adverse events in cancer clinical trials which emerged to be more accurate than those reported by physicians. He discusses the current impact and perspective for clinical practice and regulatory review of anticancer drugs.

Discussion Points

  1. Definition of patient-reported outcomes
  2. Importance of patient-reported outcomes integration into cancer clinical trials
  3. The use of patient-reported outcome measures in oncology studies: Impact on clinical practice and regulatory review